Stock SCYX SCYNEXIS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus SCYNEXIS, Inc.

Equities

SCYX

US8112922005

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-15 pm EDT 		5-day change 1st Jan Change
1.47 USD +1.73% Intraday chart for SCYNEXIS, Inc. -9.82% -34.08%
Apr. 09 SCYNEXIS, Inc. to Present Preclinical Data on Second Generation Fungerp SCY-247 at the 34th European Congress of Clinical Microbiology and Infectious Diseases CI
Mar. 28 SCYNEXIS, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Evolution of the average Target Price on SCYNEXIS, Inc.

Price target over the last 5 years

History of analyst recommendation changes

a50f6.5Mf3iyUE9WscXGZWtxHR9dc226Od5mA3g00ki1MYzbc.oKmPv3Fw2CFrGRYA50iggIN8uuvwihlm8zRx-zVTo8SJv7jyfE22P0M4BQ~ab773507f1008273d0294a6bd477b7f9

Analyst Recommendations on SCYNEXIS, Inc.

Ladenburg Thalmann Cuts SCYNEXIS Price Target to $7.50 From $15, Maintains Buy Rating MT
Guggenheim Adjusts Price Target on SCYNEXIS to $9 From $8, Maintains Buy Rating MT
Guggenheim Initiates SCYNEXIS at Buy With $8 Price Target MT
Brookline Capital Assumes SCYNEXIS at Buy With $8 Price Target MT
HC Wainwright Adjusts Price Target on SCYNEXIS to $8 From $14, Reiterates Buy Rating MT
HC Wainwright Adjusts Price Target on SCYNEXIS to $14 From $20, Reiterates Buy Rating MT
Maxim Group Adjusts SCYNEXIS Price Target to $11 From $16, Maintains Buy Rating MT
SCYNEXIS : Aegis Capital Adjusts Price Target on SCYNEXIS to $35 From $40, Reiterates Buy Rating MT
SCYNEXIS : Guggenheim Starts SCYNEXIS at Buy With $25 Price Target MT
SCYNEXIS : Cantor Fitzgerald Starts SCYNEXIS at Overweight With $30 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.47 USD
Average target price
6.875 USD
Spread / Average Target
+367.69%
High Price Target
8 USD
Spread / Highest target
+444.22%
Low Price Target
6 USD
Spread / Lowest Target
+308.16%

Consensus detail

Consensus revision (last 18 months)

Analysts covering SCYNEXIS, Inc.

Ladenburg Thalmann
Guggenheim
Brookline Capital Markets
HC Wainwright
Maxim
Aegis Capital

Ratings for SCYNEXIS, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. SCYX Stock
  4. Consensus SCYNEXIS, Inc.